Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City

Don Des Jarlais, Kamyar Arasteh, Theresa Perlis, Holly Hagan, Abu Abdul-Quader, Douglas D. Heckathorn, Courtney Mcknight, Heidi Bramson, Chris Nemeth, Lucia V. Torian, Samuel R. Friedman

Research output: Contribution to journalArticle

Abstract

OBJECTIVE: To compare HIV prevalence among injecting and non-injecting heroin and cocaine users in New York City. As HIV is efficiently transmitted through the sharing of drug-injecting equipment, HIV infection has historically been higher among injecting drug users. DESIGN: Two separate cross-sectional surveys, both with HIV counseling and testing and drug use and HIV risk behavior questionnaires. METHODS: Injecting and non-injecting heroin and cocaine users recruited at detoxification and methadone maintenance treatment from 2001-2004 (n = 2121) and recruited through respondent-driven sampling from a research storefront in 2004 (n = 448). RESULTS: In both studies, HIV prevalence was nearly identical among current injectors (injected in the last 6 months) and heroin and cocaine users who had never injected: 13% [95% confidence interval (CI), 12-15%] among current injectors and 12% (95% CI, 9-16%) among never-injectors in the drug treatment program study, and 15% (95% CI, 11-19%) among current injectors and 17% (95% CI, 12-21%) among never injectors in the respondent driven sampling storefront study. The 95% CIs overlapped in all gender and race/ethnicity subgroup comparisons of HIV prevalence in both studies. CONCLUSIONS: The very large HIV epidemic among drug users in New York City appears to be entering a new phase, in which sexual transmission is of increasing importance. Additional prevention programs are needed to address this transition.

Original languageEnglish (US)
Pages (from-to)231-235
Number of pages5
JournalAIDS
Volume21
Issue number2
DOIs
StatePublished - Jan 2007

Fingerprint

HIV Seroprevalence
Drug Users
HIV
Heroin
Cocaine
Confidence Intervals
Cross-Sectional Studies
Pharmaceutical Preparations
Sampling Studies
Methadone
Risk-Taking
HIV Infections
Counseling
Equipment and Supplies
Therapeutics

Keywords

  • HIV
  • Injecting drug users
  • New York City
  • Non-injecting drug uses
  • Seroprevalence

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. / Des Jarlais, Don; Arasteh, Kamyar; Perlis, Theresa; Hagan, Holly; Abdul-Quader, Abu; Heckathorn, Douglas D.; Mcknight, Courtney; Bramson, Heidi; Nemeth, Chris; Torian, Lucia V.; Friedman, Samuel R.

In: AIDS, Vol. 21, No. 2, 01.2007, p. 231-235.

Research output: Contribution to journalArticle

Des Jarlais, D, Arasteh, K, Perlis, T, Hagan, H, Abdul-Quader, A, Heckathorn, DD, Mcknight, C, Bramson, H, Nemeth, C, Torian, LV & Friedman, SR 2007, 'Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City', AIDS, vol. 21, no. 2, pp. 231-235. https://doi.org/10.1097/QAD.0b013e3280114a15
Des Jarlais, Don ; Arasteh, Kamyar ; Perlis, Theresa ; Hagan, Holly ; Abdul-Quader, Abu ; Heckathorn, Douglas D. ; Mcknight, Courtney ; Bramson, Heidi ; Nemeth, Chris ; Torian, Lucia V. ; Friedman, Samuel R. / Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. In: AIDS. 2007 ; Vol. 21, No. 2. pp. 231-235.
@article{aad29106483f43ac8d23d995b370c8ed,
title = "Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City",
abstract = "OBJECTIVE: To compare HIV prevalence among injecting and non-injecting heroin and cocaine users in New York City. As HIV is efficiently transmitted through the sharing of drug-injecting equipment, HIV infection has historically been higher among injecting drug users. DESIGN: Two separate cross-sectional surveys, both with HIV counseling and testing and drug use and HIV risk behavior questionnaires. METHODS: Injecting and non-injecting heroin and cocaine users recruited at detoxification and methadone maintenance treatment from 2001-2004 (n = 2121) and recruited through respondent-driven sampling from a research storefront in 2004 (n = 448). RESULTS: In both studies, HIV prevalence was nearly identical among current injectors (injected in the last 6 months) and heroin and cocaine users who had never injected: 13{\%} [95{\%} confidence interval (CI), 12-15{\%}] among current injectors and 12{\%} (95{\%} CI, 9-16{\%}) among never-injectors in the drug treatment program study, and 15{\%} (95{\%} CI, 11-19{\%}) among current injectors and 17{\%} (95{\%} CI, 12-21{\%}) among never injectors in the respondent driven sampling storefront study. The 95{\%} CIs overlapped in all gender and race/ethnicity subgroup comparisons of HIV prevalence in both studies. CONCLUSIONS: The very large HIV epidemic among drug users in New York City appears to be entering a new phase, in which sexual transmission is of increasing importance. Additional prevention programs are needed to address this transition.",
keywords = "HIV, Injecting drug users, New York City, Non-injecting drug uses, Seroprevalence",
author = "{Des Jarlais}, Don and Kamyar Arasteh and Theresa Perlis and Holly Hagan and Abu Abdul-Quader and Heckathorn, {Douglas D.} and Courtney Mcknight and Heidi Bramson and Chris Nemeth and Torian, {Lucia V.} and Friedman, {Samuel R.}",
year = "2007",
month = "1",
doi = "10.1097/QAD.0b013e3280114a15",
language = "English (US)",
volume = "21",
pages = "231--235",
journal = "AIDS",
issn = "0269-9370",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City

AU - Des Jarlais, Don

AU - Arasteh, Kamyar

AU - Perlis, Theresa

AU - Hagan, Holly

AU - Abdul-Quader, Abu

AU - Heckathorn, Douglas D.

AU - Mcknight, Courtney

AU - Bramson, Heidi

AU - Nemeth, Chris

AU - Torian, Lucia V.

AU - Friedman, Samuel R.

PY - 2007/1

Y1 - 2007/1

N2 - OBJECTIVE: To compare HIV prevalence among injecting and non-injecting heroin and cocaine users in New York City. As HIV is efficiently transmitted through the sharing of drug-injecting equipment, HIV infection has historically been higher among injecting drug users. DESIGN: Two separate cross-sectional surveys, both with HIV counseling and testing and drug use and HIV risk behavior questionnaires. METHODS: Injecting and non-injecting heroin and cocaine users recruited at detoxification and methadone maintenance treatment from 2001-2004 (n = 2121) and recruited through respondent-driven sampling from a research storefront in 2004 (n = 448). RESULTS: In both studies, HIV prevalence was nearly identical among current injectors (injected in the last 6 months) and heroin and cocaine users who had never injected: 13% [95% confidence interval (CI), 12-15%] among current injectors and 12% (95% CI, 9-16%) among never-injectors in the drug treatment program study, and 15% (95% CI, 11-19%) among current injectors and 17% (95% CI, 12-21%) among never injectors in the respondent driven sampling storefront study. The 95% CIs overlapped in all gender and race/ethnicity subgroup comparisons of HIV prevalence in both studies. CONCLUSIONS: The very large HIV epidemic among drug users in New York City appears to be entering a new phase, in which sexual transmission is of increasing importance. Additional prevention programs are needed to address this transition.

AB - OBJECTIVE: To compare HIV prevalence among injecting and non-injecting heroin and cocaine users in New York City. As HIV is efficiently transmitted through the sharing of drug-injecting equipment, HIV infection has historically been higher among injecting drug users. DESIGN: Two separate cross-sectional surveys, both with HIV counseling and testing and drug use and HIV risk behavior questionnaires. METHODS: Injecting and non-injecting heroin and cocaine users recruited at detoxification and methadone maintenance treatment from 2001-2004 (n = 2121) and recruited through respondent-driven sampling from a research storefront in 2004 (n = 448). RESULTS: In both studies, HIV prevalence was nearly identical among current injectors (injected in the last 6 months) and heroin and cocaine users who had never injected: 13% [95% confidence interval (CI), 12-15%] among current injectors and 12% (95% CI, 9-16%) among never-injectors in the drug treatment program study, and 15% (95% CI, 11-19%) among current injectors and 17% (95% CI, 12-21%) among never injectors in the respondent driven sampling storefront study. The 95% CIs overlapped in all gender and race/ethnicity subgroup comparisons of HIV prevalence in both studies. CONCLUSIONS: The very large HIV epidemic among drug users in New York City appears to be entering a new phase, in which sexual transmission is of increasing importance. Additional prevention programs are needed to address this transition.

KW - HIV

KW - Injecting drug users

KW - New York City

KW - Non-injecting drug uses

KW - Seroprevalence

UR - http://www.scopus.com/inward/record.url?scp=33845945625&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845945625&partnerID=8YFLogxK

U2 - 10.1097/QAD.0b013e3280114a15

DO - 10.1097/QAD.0b013e3280114a15

M3 - Article

C2 - 17197815

AN - SCOPUS:33845945625

VL - 21

SP - 231

EP - 235

JO - AIDS

JF - AIDS

SN - 0269-9370

IS - 2

ER -